Boardroom Alpha
Meeting calendar
MAS · Annual meeting · Friday, May 8, 2026

Masco Corp

10 nominees · 7 ballot items.

Elect four directors; advisory approval of executive compensation (say-on-pay); ratify PwC as auditors; approve three management charter amendments (limit officer liability; move advance notice provisions to bylaws; enable shareholder right to call special meetings); and vote on stockholder Proposal 7 to allow shareholders to call special meetings (10% threshold).

Market cap
$15.9B
1Y TSR
+19.5%
Board grade
B-
Record date
Mar 13, 2026
Filing
DEF 14A
Meeting concluded · May 8, 2026

Follow how the vote landed and what changed on Masco Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot7

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect directors Gary A. Coombe, Aine L. Denari, Christopher A. O’Herlihy and Charles K. Stevens to the Board for one-year terms.

  2. 2

    Advisory Vote to Approve Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding advisory vote to approve the compensation paid to the company’s named executive officers as disclosed in the proxy statement.

    More detail

    This advisory proposal asks shareholders to approve, on a non-binding basis, the compensation paid to the named executive officers as disclosed in the proxy statement. Management seeks shareholder endorsement to confirm alignment between executive pay and company performance, citing a pay-for-performance structure with annual cash bonuses tied to operating profit and net sales, LTIP metrics including cumulative EPS, ROIC and rTSR, and changes to RSU design to be forward-looking. The board recommends a FOR vote, noting prior strong shareholder support (around 91% in 2025) and ongoing shareholder engagement informing compensation design; the recommendation emphasizes that the vote is advisory but will be considered by the Compensation Committee in future decisions.

  3. 3

    Ratification of Selection of Independent Auditors

    ManagementBoard: FOR

    Ratify PricewaterhouseCoopers LLP as the company’s independent auditors for 2026.

  4. 4

    Amend Certificate to Limit Officer Liability

    ManagementBoard: FOR

    Approve amendments to the Certificate of Incorporation to limit the monetary liability of certain officers to the fullest extent permitted by Delaware law (DGCL Section 102(b)(7)); simplifies director exculpation language.

  5. 5

    Move Advance Notice Provisions to Bylaws and Amend Periods

    ManagementBoard: FOR

    Amend the Certificate to remove advance notice provisions for stockholder nominations and allow the Board to move and revise the advance notice timing and information requirements in the Bylaws (changing to 90–120 day windows).

  6. 6

    Amend Certificate to Enable Shareholders to Call Special Meetings

    ManagementBoard: FOR

    Amend the Certificate to permit adoption of a shareholders’ right to call special meetings; contingent Bylaw amendment would allow shareholders owning 25% of voting power, with one-year continuous ownership, to request Board to call a special meeting, subject to procedural and informational requirements and exclusion criteria.

    More detail

    Proposal 6 asks shareholders to approve a charter amendment enabling the Board to adopt a shareholder right to call special meetings and contemplates a bylaw implementing a 25% ownership-and-one-year holding requirement for shareholders to request a special meeting, with detailed procedural and informational requirements and exclusions. Management is seeking approval to expand shareholder rights while setting a relatively high ownership threshold (25%) to limit frivolous or burdensome special meetings; the Board recommends FOR, arguing the threshold balances shareholder access with protection from undue disruption and notes 25% is common among S&P 500 firms.

  7. 7

    Stockholder Proposal—Give Shareholders an Ability to Call for a Special Shareholder Meeting

    Shareholder — John CheveddenBoard: AGAINST

    Stockholder proposal (John Chevedden) requesting the company amend governing documents to allow shareholders owning 10% of outstanding common stock to call a special shareholder meeting, without ownership period requirement.

    More detail

    Shareholder Proposal 7 requests that the company amend its governing documents to allow shareholders holding 10% of outstanding common stock to call a special meeting without ownership-period restrictions, arguing this strengthens accountability and is supported at peer companies; management opposes and has offered Proposal 6 to enable a 25%/one-year threshold instead. The dispute centers on balancing shareholder rights and responsiveness versus the risk of disruptive or costly special meetings; management emphasizes a higher 25% threshold and procedural protections to avoid opportunistic use, while the proponent cites precedents and recent company underperformance as justification for easier shareholder access.

Director elections

Nominees on the ballot10

Independent
Tenure on this board
8.5 yrs
Also a director at
Flex Ltd (FLEX)Genuine Parts Co (GPC)
Independent
Tenure on this board
8.9 yrs
Also a director at
Valero Energy Corp (VLO)
Independent
Tenure on this board
14.2 yrs
Also a director at
Jabil Inc (JBL)Howmet Aerospace Inc (HWM)
Independent
Tenure on this board
19.6 yrs
Also a director at
Rockwell Automation Inc (ROK)
Ownership

Top institutional holders10

Latest 13F quarter
1VANGUARD CAPITAL MANAGEMENT LLC6.6%13,224,747$798M
2VANGUARD PORTFOLIO MANAGEMENT LLC6.1%12,351,666$746M
3STATE STREET CORP4.9%9,959,319$601M
4HARRIS ASSOCIATES L P4.2%8,442,141$510M
5BlackRock, Inc.3.6%7,336,243$443M
6VAN ECK ASSOCIATES CORP2.9%5,842,483$353M
7JPMORGAN CHASE CO2.7%5,418,622$318M
8GEODE CAPITAL MANAGEMENT, LLC2.3%4,697,996$282M
9BlackRock, Inc.2.1%4,151,172$251M
10WELLINGTON MANAGEMENT GROUP LLP2.0%4,028,959$243M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Masco Corp 2026 annual meeting?
Masco Corp (MAS) holds its 2026 annual shareholder meeting on Friday, May 8, 2026.
What is the record date for the Masco Corp 2026 meeting?
The record date for the Masco Corp 2026 meeting is Friday, March 13, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Masco Corp's 2026 meeting?
The board is presenting 10 director nominees at the Masco Corp 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Masco Corp 2026 meeting?
Shareholders will vote on 7 proposals at the Masco Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer